Genfit Names Pejvack Motlagh as Chief Medical Officer
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 28 2025
0mins
Source: NASDAQ.COM
Appointment Announcement: Genfit has appointed Pejvack Motlagh as its new Chief Medical Officer.
Professional Background: Motlagh brings over 20 years of experience in the pharmaceutical and biotechnology sectors, having previously served as CMO at Egle Therapeutics and Mablink Biosciences.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like undefined with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
